Envista Holdings Corporation (NVST)
| Market Cap | 6.83B |
| Revenue (ttm) | 2.28B |
| Net Income (ttm) | 33.30M |
| Shares Out | 159.60M |
| EPS (ttm) | 1.60 |
| PE Ratio | 26.51 |
| Forward PE | 27.47 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | April 19 |
| Last Price | $42.37 |
| Previous Close | $42.52 |
| Change ($) | -0.15 |
| Change (%) | -0.35% |
| Day's Open | 42.28 |
| Day's Range | 42.19 - 42.61 |
| Day's Volume | 195,551 |
| 52-Week Range | 14.73 - 45.00 |
BREA, Calif., April 15, 2021 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its first quarter 2021 on Wednesday, May 5, 2021.
Envista (NVST) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
NEW YORK, April 6, 2021 /PRNewswire/ -- Envista Holdings Corp. (NYSE: NVST) will replace InterDigital Inc. (NASD: IDCC) in the S&P MidCap 400, and InterDigital will replace SEACOR Holdings Inc. (NYSE: C...
Envista (NVST) delivered earnings and revenue surprises of 40.00% and 10.75%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Shares of Envista Holdings (NYSE:NVST) remained unaffected after the company reported Q4 results. Quarterly Results Earnings per share increased 7.69% over the past year to $0.56, which beat the estimat...
Envista (NVST) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BREA, Calif., Jan. 26, 2021 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its fourth quarter 2020 on Wednesday, February 10, 2021. Envista will ...
BREA, Calif., Jan. 5, 2021 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in the JP Morgan Healthcare Conference on Monday, Janua...
Is Envista Holdings (NVST) a great pick from the value investor's perspective right now? Read on to know more.
BREA, Calif., Nov. 10, 2020 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in the Wolfe Research Virtual Healthcare Conference on...
Envista Holdings went public in September 2019. The firm is separating from parent company Danaher and provides dental equipment and products worldwide.
Envista Holdings Corporation (NVST) CEO Amir Aghdaei on Q3 2020 Results - Earnings Call Transcript
Envista (NVST) delivered earnings and revenue surprises of 433.33% and 25.79%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Shares of Envista Holdings (NYSE:NVST) moved higher by 4.29% in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share increased 2.13% over the past year to $0....
BREA, Calif., Oct. 29, 2020 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced results for the third quarter 2020. For the third quarter, the Company's net income was $35.6 millio...
Envista (NVST) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BREA, Calif., Oct. 14, 2020 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its third quarter 2020 on Thursday, October 29, 2020. Envista will dis...
BREA, Calif., Aug. 31, 2020 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in the Baird 2020 Global Healthcare Conference on Wedn...
These 5 healthcare stocks look like the sector's best, with downside protection and room for price appreciation even if the market falters.
Envista Holdings Corporation (NVST) CEO Amir Aghdaei on Q2 2020 Results - Earnings Call Transcript
BREA, Calif., July 21, 2020 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its second quarter 2020 on Thursday, July 30, 2020.
Amid a weeks-long rally in stocks, some investors may already have forgotten how painful it was when the market crashed in late February and March.
BREA, Calif., May 26, 2020 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will virtually participate in the Stifel 2020 Jaws & Paws Conference on ...
Taking the long view, NVST looks attractive, as a defensive business should hold up once some semblance of normalcy returns.
BREA, Calif., May 18, 2020 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced the pricing of its offering of $450,000,000 aggregate principal amount of 2.375% convertible senior n...
BREA, Calif., May 18, 2020 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced its intention to offer, subject to market and other conditions, $400,000,000 aggregate principal amou...
Envista Holdings Corporation (NVST) CEO Amir Aghdaei on Q1 2020 Results - Earnings Call Transcript
Envista Holdings (NVST) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Envista (NVST) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Envista Holdings Corporation (NVST) CEO Amir Aghdaei on Q4 2019 - Earnings Call Transcript
These two dental products companies battle for investors’ attention. Which stock is more attractive?
NVST vs. GNNDY: Which Stock Is the Better Value Option?
About NVST
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, and markets dental products in the United States and internationally. The company operates in two segments, Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, prefabricated and custom-built prosthetics, and dental eye loupes to oral surgeons, prosthodontists, and periodontists under the brands, including Nobel Biocare, Alph... [Read more...]
| Industry Medical Instruments & Supplies | IPO Date Sep 18, 2019 |
| CEO Amir Aghdaei | Employees 12,400 |
| Stock Exchange NYSE | Ticker Symbol NVST |
Financial Performance
In 2020, NVST's revenue was $2.28 billion, a decrease of -17.07% compared to the previous year's $2.75 billion. Earnings were $33.30 million, a decrease of -84.70%.
Analyst Forecasts
According to 12 analysts, the average rating for NVST stock is "Buy." The 12-month stock price forecast is 45.30, which is an increase of 6.92% from the latest price.